Cargando…
Neutral sphingomyelinase-2, acid sphingomyelinase, and ceramide levels in COPD patients compared to controls
BACKGROUND: Increased pulmonary ceramide levels are suggested to play a causative role in lung diseases including COPD. Neutral sphingomyelinase-2 (nSMase-2) and acid SMase (aSMase), which hydrolyze sphingomyelin to produce ceramide, are activated by a range of cellular stresses, including inflammat...
Autores principales: | Lea, Simon R, Metcalfe, Hannah J, Plumb, Jonathan, Beerli, Christian, Poll, Chris, Singh, Dave, Abbott-Banner, Katharine H |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Dove Medical Press
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5019168/ https://www.ncbi.nlm.nih.gov/pubmed/27660431 http://dx.doi.org/10.2147/COPD.S95578 |
Ejemplares similares
-
The acid sphingomyelinase/ceramide system in COVID-19
por: Kornhuber, Johannes, et al.
Publicado: (2021) -
Remodeling of cellular cytoskeleton by the acid sphingomyelinase/ceramide pathway
por: Zeidan, Youssef H., et al.
Publicado: (2008) -
Alterations of the Ceramide Metabolism in the Peri-Infarct Cortex Are Independent of the Sphingomyelinase Pathway and Not Influenced by the Acid Sphingomyelinase Inhibitor Fluoxetine
por: Brunkhorst, R., et al.
Publicado: (2015) -
Sphingomyelinase D/Ceramide 1-Phosphate in Cell Survival and Inflammation
por: Rivera, Io-Guané, et al.
Publicado: (2015) -
Amyloid-β peptide induces oligodendrocyte death by activating the neutral sphingomyelinase–ceramide pathway
por: Lee, Jiunn-Tay, et al.
Publicado: (2004)